title: [Chronic kidney disease].
authors.affiliation: Medizinische Klink III, Nephrologische Abteilung, Klinikum Coburg. markus.ketteler@klinikum-coburg.de
authors.forename: M
authors.initials: M
authors.lastname: Ketteler
authors.forename: C
authors.initials: C
authors.lastname: Wanner
mesh_terms: D000577:Amides / Q000009:adverse effects / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000097:blood; D005650:Fumarates / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000097:blood / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D007677:Kidney Function Tests; D010710:Phosphates / Q000097:blood; D011237:Predictive Value of Tests; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment
chemical_list: D000577:Amides; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D005650:Fumarates; D010710:Phosphates; C446481:aliskiren; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23